From April 1, 2024 to June 30, 2024, the company has repurchased 8,823,000 shares, representing 0.64% for CNY 44.99 million. With this, the company has completed the repurchase of 20,491,812 shares, representing 1.48% for CNY 129.61 million under the buyback announced on February 3, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.1 CNY | -2.52% |
|
+0.98% | -61.78% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-61.78% | 587M | |
+13.97% | 4.99B | |
-32.08% | 3.61B | |
-1.63% | 3.1B | |
-24.62% | 2.64B | |
-9.82% | 2.32B | |
+38.87% | 1.85B | |
+38.84% | 1.43B | |
-15.47% | 1.39B | |
+40.95% | 1.37B |
- Stock Market
- Equities
- 002424 Stock
- News Guizhou Bailing Group Pharmaceutical Co., Ltd.
- Tranche Update on Guizhou Bailing Group Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 3, 2024.